These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24598691)

  • 1. [New advances in the subtyping of systemic amyloidosis].
    Sun WY; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.
    Vrana JA; Gamez JD; Madden BJ; Theis JD; Bergen HR; Dogan A
    Blood; 2009 Dec; 114(24):4957-9. PubMed ID: 19797517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
    Tasaki M; Obayashi K; Ueda M; Ando Y
    Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stepwise data interpretation process for renal amyloidosis typing by LMD-MS.
    Ke M; Li X; Wang L; Yue S; Zhao B
    BMC Nephrol; 2022 Apr; 23(1):144. PubMed ID: 35418036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in molecular diagnosis: typing of amyloidosis.
    Loo D; Mollee PN; Renaut P; Hill MM
    J Biomed Biotechnol; 2011; 2011():754109. PubMed ID: 22131817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
    Klein CJ; Vrana JA; Theis JD; Dyck PJ; Dyck PJ; Spinner RJ; Mauermann ML; Bergen HR; Zeldenrust SR; Dogan A
    Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing.
    Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL
    Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry.
    Gonzalez Suarez ML; Zhang P; Nasr SH; Sathick IJ; Kittanamongkolchai W; Kurtin PJ; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera Hernandez LP; Said SM; Sethi S; Dispenzieri A; Gertz MA; Leung N
    Kidney Int; 2019 Oct; 96(4):1005-1009. PubMed ID: 31447055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry based proteomics in the diagnosis of kidney disease.
    Sethi S; Vrana JA; Theis JD; Dogan A
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):273-80. PubMed ID: 23470817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
    Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
    Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
    Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
    Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites.
    Holub D; Flodrova P; Pika T; Flodr P; Hajduch M; Dzubak P
    Biomed Res Int; 2019; 2019():3689091. PubMed ID: 30834260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical typing of amyloid in fixed paraffin-embedded samples by an automatic procedure: Comparison with immunofluorescence data on fresh-frozen tissue.
    Barreca A; Bottasso E; Veneziano F; Giarin M; Nocifora A; Martinetti N; Attanasio A; Biancone L; Benevolo G; Roccatello D; Cassoni P; Papotti MG;
    PLoS One; 2021; 16(8):e0256306. PubMed ID: 34428239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to diagnose amyloidosis.
    Mollee P; Renaut P; Gottlieb D; Goodman H
    Intern Med J; 2014 Jan; 44(1):7-17. PubMed ID: 24024789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Light Chain Amyloidosis: an Update for Treatment].
    Shen KN; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):910-4. PubMed ID: 26117060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.